about
Prevalence of Depression in Patients With Mild Cognitive Impairment: A Systematic Review and Meta-analysis.Relating education, brain structure, and cognition: the role of cardiovascular disease risk factorsHigh "normal" blood glucose is associated with decreased brain volume and cognitive performance in the 60s: the PATH through life study.Evaluation of a research diagnostic algorithm for DSM-5 neurocognitive disorders in a population-based cohort of older adultsApathy associated with neurocognitive disorders: Recent progress and future directions.Blood pressure, brain structure, and cognition: opposite associations in men and women.Affective and emotional dysregulation as pre-dementia risk markers: exploring the mild behavioral impairment symptoms of depression, anxiety, irritability, and euphoria.Depressive symptoms in later life: differential impact of social support and motivational processes on depression in individuals with and without cognitive impairment.Prevalence estimates of mild behavioral impairment in a population-based sample of pre-dementia states and cognitively healthy older adults.Prevalence of mild behavioral impairment in mild cognitive impairment and subjective cognitive decline, and its association with caregiver burden.Neuropsychiatric Symptoms and Cognitive Impairment: Understanding the Importance of Co-Morbid Symptoms.Caregiver rating bias in mild cognitive impairment and mild Alzheimer's disease: impact of caregiver burden and depression on dyadic rating discrepancy across domains.Differential associations between sensory loss and neuropsychiatric symptoms in adults with and without a neurocognitive disorder.Using sulcal and gyral measures of brain structure to investigate benefits of an active lifestyle.Dementia clinical trial implications of mild behavioral impairment.Depressive symptoms as a barrier to engagement in physical activity in older adults with and without Alzheimer's diseaseGreater cognitive decline relative to normal ageing occurs at least 10 years prior to clinical dementia diagnosis
P50
Q30239766-01052BF0-BC47-40FF-B557-D22E26B3C011Q34092951-9375A7D9-6446-48FF-9C3C-1E55FD72F296Q34984519-B606FC8F-2819-4F19-8D26-5C3B8C6B80E0Q37680175-72F9A8C3-E4C7-4E3D-8AB7-A08CA7C11367Q38846813-FB5D3A31-9358-44DC-B652-3903450CA3C8Q39139524-0F599D07-1EAF-4088-9C2C-2828BD66B9F9Q40045052-981B1998-C44C-4898-83D6-646E701CC36EQ41315416-3024B750-FE45-4BA6-B669-6FACD5628E70Q47319800-B2E47436-98E8-4849-88C1-AC21D5B7731BQ47322692-CD6E492C-07B5-4B9D-BAC5-8CD535F92386Q47698396-71107A69-5322-403A-824D-CBC93B22DC4DQ48022373-1DEC6BF2-14CC-427B-81E9-F66A6144FC42Q48099839-0E349303-B7C9-452A-A59E-4A9F12E97C36Q48369455-5DAE47F1-768C-4598-A1EB-84308D5CF8FAQ49962843-554885EE-DC8B-445F-BB77-F6697EF3A813Q60305757-E7374668-D19B-49E7-9F50-6104921ABBCBQ88211180-031B61F1-327C-4DBB-9654-34841CBA39C5
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-9568-6628
@en
name
Moyra E Mortby
@ast
Moyra E Mortby
@en
Moyra E Mortby
@es
Moyra E Mortby
@nl
type
label
Moyra E Mortby
@ast
Moyra E Mortby
@en
Moyra E Mortby
@es
Moyra E Mortby
@nl
prefLabel
Moyra E Mortby
@ast
Moyra E Mortby
@en
Moyra E Mortby
@es
Moyra E Mortby
@nl
P106
P1153
48361432900
P31
P496
0000-0002-9568-6628